Early drug development: paving the way to patient-centred design
Adding precision to dose-finding in early-phase clinical trials has become critical in the immunotherapy era, and moving away from paradigms of the past has become mandatory
Disclose or not disclose – COIs mismanagement erodes public trust
There is a broader negligence of the public health consequences of individual actions among the health providers
You are not your COI, but COI can make you
There is a misunderstanding in what financial conflict of interests do on single people and what system implications they may have
Double standards in healthcare: a modern hypocrisy
Having treatment protocols for the rich countries and alternative protocols for the poor ones still nurtures global health disparities
Fair pricing in an unfair world — where is the value?
People think cancer care is unaffordable because of the high prices of cancer medicines. Some state that innovations in oncology mostly happen thanks to massive investments in the private sector.
One step back to move forward in oncology workforce
The scope of the oncology care across resource-diverse settings has been long debated.
Making assumptions about COVID-19 and cancer: a way to harm all
Are we ready to accept uncertainty in the name of cancer care sustainability?
The sustainability of health systems is critical for achieving a durable impact on population health.